Protea is a leader in the emerging field of Bioanalytics. The company develops new technology for the identification, characterization, and quantitation of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications.

Bioanalytics is the direct identification and characterization of the products of all living cells, including proteins, lipids, metabolites and nucleic acids. Bioanalytics is emerging as a crucial area, where new technology is needed to support the future of medical research, and virtually every other field of life science research.

We develop new bioanalytical methods that enable the direct analysis of proteins and other biomolecules, and apply our capabilities to support your laboratory’s research objectives.

Register online to receive updates on our new products and services.




“We are leading a new, emerging era of biology, one where new bioanalytical technologies will rapidly and directly identify proteins, metabolites and other biomolecules, where even their molecular interactions in cells can be directly analyzed, an era that will be a major catalyst for the next generation of pharmaceutical development”
                  – Steve Turner, CEO